Literature DB >> 20495109

Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure.

Bart Boerrigter1, Gert-Jan Mauritz, J Tim Marcus, Frank Helderman, Pieter E Postmus, Nico Westerhof, Anton Vonk-Noordegraaf.   

Abstract

BACKGROUND: Pulmonary artery (PA) dilatation is one of the consequences of pulmonary arterial hypertension (PAH) and is used for noninvasive detection. However, it is unclear how the size of the PA behaves over time and whether it is related to pressure changes. The aim of this study was to evaluate PA size during follow-up in treated patients with PAH and whether it reflects pulmonary vascular hemodynamics.
METHODS: Fifty-one patients with PAH who underwent at least two right-sided heart catheterizations (RHCs) together with cardiac MRI (CMR) were included in this study. Another 18 patients who had normal pressure at RHC were included for comparison at baseline. From RHC, we derived PA pressures and cardiac output. From the CMR images we derived PA diameter (PAD) and the ratio of the PAD and ascending aorta diameter.
RESULTS: The PAD was significantly larger in patients with PAH than in patients without PAH (P < .001). A ratio of the PAD and ascending aorta diameter > 1 had a positive predictive value of 92% for PAH. Mean follow-up time was 942 days, and there was a significant dilatation during this period (P < .001). The change of the PAD did not correlate with the changes in pressure or cardiac output. A moderate correlation with follow-up time was found (r = 0.56; P < .001).
CONCLUSIONS: A dilatated PA is useful for identifying patients with PAH. However, during patient follow-up, progressive dilatation of the PA is independent of the change in PA pressure and cardiac output and might become independent from hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495109     DOI: 10.1378/chest.10-0363

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report.

Authors:  Inês Araújo; Pilar Escribano; María Jesus Lopez-Gude; Carmen Jimenez Lopez-Guarch; Maria Antonia Sanchez; Maria J Ruiz-Cano; Juan Delgado; Jose Cortina
Journal:  BMC Cardiovasc Disord       Date:  2011-10-21       Impact factor: 2.298

3.  Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension.

Authors:  Jordan C Ray; Charles Burger; Patricia Mergo; Robert Safford; Joseph Blackshear; Christopher Austin; DeLisa Fairweather; Michael G Heckman; Tonya Zeiger; Marcia Dubin; Brian Shapiro
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-22       Impact factor: 2.357

Review 4.  Significance of main pulmonary artery dilation on imaging studies.

Authors:  Timothy E Raymond; Joseph E Khabbaza; Ruchi Yadav; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2014-12

5.  Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.

Authors:  Matthias Eberhard; Monika Mastalerz; Jovana Pavicevic; Thomas Frauenfelder; Fabian Nietlispach; Francesco Maisano; Felix C Tanner; Thi Dan Linh Nguyen-Kim
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-26       Impact factor: 2.357

6.  Changes in main pulmonary artery diameter during follow-up have prognostic implications in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Scott Johnson; Laith Alkukhun; Ruchi Yadav; Raed A Dweik
Journal:  Respirology       Date:  2017-05-17       Impact factor: 6.424

7.  A non-invasive assessment of cardiopulmonary hemodynamics with MRI in pulmonary hypertension.

Authors:  Octavia Bane; Sanjiv J Shah; Michael J Cuttica; Jeremy D Collins; Senthil Selvaraj; Neil R Chatterjee; Christoph Guetter; James C Carr; Timothy J Carroll
Journal:  Magn Reson Imaging       Date:  2015-08-14       Impact factor: 2.546

8.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

9.  Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.

Authors:  J Michael Wells; Joshua B Morrison; Surya P Bhatt; Hrudaya Nath; Mark T Dransfield
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

10.  Main pulmonary arterial wall shear stress correlates with invasive hemodynamics and stiffness in pulmonary hypertension.

Authors:  Michal Schäfer; Vitaly O Kheyfets; Joyce D Schroeder; Jamie Dunning; Robin Shandas; J Kern Buckner; James Browning; Jean Hertzberg; Kendall S Hunter; Brett E Fenster
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.